Trial Details

Not Recruiting
Basic Information
Clinical ID c4970
Identifier ISRCTN82615441
Trial Title A multi-centre, randomised, controlled, phase iii study to investigate the safety and efficacy of intravenous infusions of VIT-45 in patients with iron deficiency anaemia secondary to chronic inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Iron deficiency anaemia secondary to chronic inflammatory bowel disease Signs and Symptoms
Interventions 1. Patients in the experimental arm received VIT-45 as an infusion on Day 1, with subsequent infusions at weekly intervals up to a maximum of 1000 mg iron per dose. The doses were continued until the patient received the cumulative dose based on their ind
Participant Information
Sponsor Vifor (International) Inc.
City NULL
Country/Region Argentina;Austria;Belgium;Bulgaria;Mexico;Poland;Russia;Ukraine
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase PHASE3
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL